V Square Quantitative Management LLC Has $1.42 Million Stock Holdings in Colgate-Palmolive (NYSE:CL)

V Square Quantitative Management LLC boosted its stake in shares of Colgate-Palmolive (NYSE:CLFree Report) by 1.7% in the fourth quarter, HoldingsChannel reports. The firm owned 15,598 shares of the company’s stock after purchasing an additional 266 shares during the quarter. V Square Quantitative Management LLC’s holdings in Colgate-Palmolive were worth $1,418,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of CL. Union Bancaire Privee UBP SA bought a new position in Colgate-Palmolive in the 4th quarter valued at about $32,000. Hager Investment Management Services LLC bought a new position in shares of Colgate-Palmolive during the fourth quarter worth approximately $36,000. Reston Wealth Management LLC acquired a new stake in Colgate-Palmolive during the 3rd quarter worth approximately $42,000. Capital Performance Advisors LLP bought a new stake in Colgate-Palmolive in the 3rd quarter valued at $53,000. Finally, Synergy Asset Management LLC acquired a new position in Colgate-Palmolive in the 4th quarter valued at $49,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $87.87 on Friday. The company has a market capitalization of $71.79 billion, a PE ratio of 24.96, a P/E/G ratio of 4.12 and a beta of 0.44. Colgate-Palmolive has a fifty-two week low of $82.83 and a fifty-two week high of $109.30. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.26 and a current ratio of 0.41. The company has a 50 day simple moving average of $89.83 and a two-hundred day simple moving average of $96.54.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the prior year, the firm earned $0.87 earnings per share. Research analysts anticipate that Colgate-Palmolive will post 3.73 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be given a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.28%. Colgate-Palmolive’s payout ratio is 56.82%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the company. JPMorgan Chase & Co. dropped their target price on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a report on Monday, February 3rd. UBS Group decreased their target price on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research report on Monday, February 3rd. Piper Sandler cut their price target on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. Wells Fargo & Company lowered their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research note on Tuesday, January 7th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and set a $101.00 target price on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. One analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $101.16.

Read Our Latest Report on Colgate-Palmolive

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.